Clinical Trials List
Protocol NumberMEOMG1A20170313
2018-01-02 - 2020-01-07
Phase I/II
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14-30 participants
-
Global
14-30 participants
